Seguir
Hajime Uno
Hajime Uno
Dana-Farber Cancer Institute/Havard Medical School
Dirección de correo verificada de ds.dfci.harvard.edu - Página principal
Título
Citado por
Citado por
Año
On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
H Uno, T Cai, MJ Pencina, RB D'Agostino, LJ Wei
Statistics in medicine 30 (10), 1105-1117, 2011
13172011
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
T Davoli, H Uno, EC Wooten, SJ Elledge
Science 355 (6322), eaaf8399, 2017
11262017
Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis
H Uno, B Claggett, L Tian, E Inoue, P Gallo, T Miyata, D Schrag, ...
Journal of clinical Oncology 32 (22), 2380, 2014
6302014
Erythropoietic response and outcomes in kidney disease and type 2 diabetes
SD Solomon, H Uno, EF Lewis, KU Eckardt, J Lin, EA Burdmann, ...
New England Journal of Medicine 363 (12), 1146-1155, 2010
5302010
Cancer susceptibility gene mutations in individuals with colorectal cancer
MB Yurgelun, MH Kulke, CS Fuchs, BA Allen, H Uno, JL Hornick, ...
Journal of Clinical Oncology 35 (10), 1086, 2017
4892017
Evaluating Prediction Rules for t-Year Survivors With Censored Regression Models
H Uno, T Cai, L Tian, LJ Wei
Journal of the American Statistical Association 102 (478), 527-537, 2007
3952007
Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction
CL Hung, A Verma, H Uno, SH Shin, M Bourgoun, AH Hassanein, ...
Journal of the American College of Cardiology 56 (22), 1812-1822, 2010
3562010
A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data
H Uno, L Tian, T Cai, IS Kohane, LJ Wei
Statistics in medicine 32 (14), 2430-2442, 2013
3392013
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled …
LD Cripe, H Uno, EM Paietta, MR Litzow, RP Ketterling, JM Bennett, ...
Blood, The Journal of the American Society of Hematology 116 (20), 4077-4085, 2010
2742010
Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial
PG Richardson, RJ Soiffer, JH Antin, H Uno, Z Jin, J Kurtzberg, PL Martin, ...
Biology of Blood and Marrow Transplantation 16 (7), 1005-1017, 2010
2692010
Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients
E Platz, EF Lewis, H Uno, J Peck, E Pivetta, AA Merz, D Hempel, C Wilson, ...
European heart journal 37 (15), 1244-1251, 2016
2662016
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
AC Pouleur, E Barkoudah, H Uno, H Skali, PV Finn, SL Zelenkofske, ...
Circulation 122 (6), 597-602, 2010
2412010
Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection
JL Lyons, H Uno, P Ancuta, A Kamat, DJ Moore, EJ Singer, S Morgello, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 57 (5), 371-379, 2011
2352011
On the restricted mean survival time curve in survival analysis
L Zhao, B Claggett, L Tian, H Uno, MA Pfeffer, SD Solomon, L Trippa, ...
Biometrics 72 (1), 215-221, 2016
2292016
Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection
A Kamat, JL Lyons, V Misra, H Uno, S Morgello, EJ Singer, D Gabuzda
JAIDS Journal of Acquired Immune Deficiency Syndromes 60 (3), 234-243, 2012
2212012
Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio
K Pak, H Uno, DH Kim, L Tian, RC Kane, M Takeuchi, H Fu, B Claggett, ...
JAMA oncology 3 (12), 1692-1696, 2017
2142017
Alternatives to hazard ratios for comparing the efficacy or safety of therapies in noninferiority studies
H Uno, J Wittes, H Fu, SD Solomon, B Claggett, L Tian, T Cai, MA Pfeffer, ...
Annals of internal medicine 163 (2), 127-134, 2015
2072015
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet …
H Skali, H Uno, AS Levey, LA Inker, MA Pfeffer, SD Solomon
American heart journal 162 (3), 548-554, 2011
1812011
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD
AS Desai, R Toto, P Jarolim, H Uno, KU Eckardt, R Kewalramani, ...
American Journal of Kidney Diseases 58 (5), 717-728, 2011
1762011
Restricted mean survival time as a measure to interpret clinical trial results
DH Kim, H Uno, LJ Wei
JAMA cardiology 2 (11), 1179-1180, 2017
1652017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20